| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8450338 | FERRING PHARMS INC | Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof |
Oct, 2028
(4 years from now) | |
| US8481083 | FERRING PHARMS INC | Granular compositions of magnesium oxide and citric acid and uses thereof |
Oct, 2028
(4 years from now) | |
Prepopik is owned by Ferring Pharms Inc.
Prepopik contains Citric Acid; Magnesium Oxide; Sodium Picosulfate.
Prepopik has a total of 2 drug patents out of which 0 drug patents have expired.
Prepopik was authorised for market use on 16 July, 2012.
Prepopik is available in for solution;oral dosage forms.
The generics of Prepopik are possible to be released after 10 October, 2028.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Aug 15, 2021 |
| New Product(NP) | Jul 16, 2015 |
Drugs and Companies using CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE ingredient
Market Authorisation Date: 16 July, 2012
Treatment: NA
Dosage: FOR SOLUTION;ORAL
How can I launch a generic of PREPOPIK before it's drug patent expiration?
More Information on Dosage
PREPOPIK family patents
